Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/30/2008 First Published: 6/1/1999


1.		Phase III Randomized Study of Oral Carboxyamidotriazole in Patients With Stage III or IV Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				NCCTG-972451 NCT00003869, NCCTG-97-24-51

Last Modified: 11/1/2000


2.		Phase I/II Study of Daily Oral Carboxyaminoimidazole (CAI) for Refractory Solid Tumors or Lymphoma (Summary Last Modified 11/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 or over				NCI				WCCC-CO-9397 NCI-T93-0193C, T93-0193

Last Modified: 9/1/1998


3.		Phase II Study of Oral Carboxyamidotriazole in Patients with Androgren-Independent Prostate Cancer (Summary Last Modified 09/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-97-C-0059C NCI-T96-0053, T96-0053

Last Modified: 12/19/2003 First Published: 5/1/1998


4.		Phase II Study of Carboxyamidotriazole in Patients with Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-98-C-0012 NCI-T97-0112, T97-0112, NCT00019461

Last Modified: 11/6/2006 First Published: 12/1/1999


5.		Phase II Study of Carboxyamidotriazole With Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				NABTT-9904 JHOC-NABTT-9904, NCT00004146

Last Modified: 12/13/2005 First Published: 4/1/2000


6.		Phase II Study of Carboxyamidotriazole in Patients With Advanced Renal Cell Cancer Refractory to Immunotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ECOG-4896 NCT00005045, E4896

Last Modified: 9/26/2006 First Published: 11/1/2000


7.		Phase II Randomized Study of Carboxyamidotriazole in Patients With Metastatic Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				CLB-69901 NCT00006486, CALGB-69901

Last Modified: 10/10/2008


8.		Phase I Study of Carboxyamidotriazole Plus Paclitaxel in Patients With Advanced Solid Tumors or Refractory Lymphomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				Over 18				NCI				NCI-95-C-0015F NCI-CPB-334, NCI-T94-0006N, T94-0006, NCT00019019

Last Modified: 1/1/2001 First Published: 4/1/1998


9.		Phase I Study of Carboxyamidotriazole Modulated by Ketoconazole in Patients with Advanced Malignancies (Summary Last Modified 01/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				UCCRC-9019 NCI-T97-0086, NCT00003249, T97-0086

Last Modified: 12/1/1998


10.		Phase I Study of Carboxyamidotriazole for Refractory Cancers (Summary Last Modified 12/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				over 18				NCI				NCI-92-C-0054P NCI-MB-281, NCI-T91-0170N, T91-0170

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute